Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 3, 2003 - Issue 1
Submit an article Journal homepage
21
Views
7
CrossRef citations to date
0
Altmetric
Review

Health-related quality of life assessment in chronic kidney disease

Emily Beth Devine Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195-7630, USA. [email protected]
,
Karen L Smith Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195-7630, USA. [email protected]
,
Catherine Stehman-Breen Nephrology, Veterans Administration Puget Sound Healthcare System, Renal Unit, Adjunct Assistant Professor, Epidemiology, School of Public Health and Community Medicine, 1660 S. Columbian Way, MS 111A, Seattle, WA, USA. [email protected]
&
Donald L Patrick Department of Health Services, School of Public Health and Community Medicine, Adjunct Professor, School of Pharmacy, University of Washington, Box 357660, Seattle, WA 98195-7660, USA. [email protected]
Pages 89-100 | Published online: 09 Jan 2014

References

  • Jones C, McQuillan G, Kusek J etal. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney DA 32, 992–999 (1998).
  • National Kidney Foundation Dialysis Outcomes Quality Initiative: Clinical Practice Guideline. Am J. ladney Dis. 30\(Suppl. 2), S95—S100 (1997).
  • Young E. An improved understanding of the causes of end stage renal disease. Semin. Nephrol 17, 170–175 (1997).
  • Zabetakis P, Nissenson A. Complications of chronic renal insufficiency: Beyond cardiovascular disease. Am. J. 'Wiley Dis. 36, S31—S38 (2000).
  • Wight J, Edwards L, Brazier J, Walters S, Payne J, Brown C. The SF36 as an outcome measure of services for end stage renal failure. Quality in Healthcate7, 209–221 (1998).
  • Patrick D, Erickson P Health Status and Health Policy: Allocating Resources of Healthcare. Oxford University Press. New York, NY, USA (1993).
  • ••Excellent text that provides a comprehensiveoverview of the topic of HRQOL.
  • Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Quail Life Res. 11(3), 193–220 (2002).
  • Liang MH, Lew RA, Stucki G, Fortin PR, Daltroy L. Measuring clinically important changes with patient-oriented questionnaires. Med Cain 40(4 Supp0, 1145–51 (2002).
  • Furth S, Gerson A, Neu A, Fivush B. The impact of dialysis and transplantation on children. Adv Ren. Replace 7-her 8,206–213 (2001).
  • Bergner M, Bobbitt R, Kressel S, Pollard W Gibson B, Morris J. The Sickness Impact Profile: Conceptual formulation and methodology for the development of a health status measure. Lit. J. Health Serv 6, 393–415 (1978).
  • Bergner M, Bobbitt R, Kressell S, Pollard W Gibson B, Morris J. The Sickness Impact Profile: Development and fmal revision of a health status measure. Med Cate 19, 787–805 (1981).
  • Evans R, Rader B, Manninen D. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAIVIA 263, 825–830 (1990).
  • •One of the first studies to describe the use of erythropoietin.
  • Hart L, Evans R. The functional status of ESRD patients as measured by the sickness impact profile. J. Chron. Dis. 40 (Suppl.), 117S-130S (1987).
  • Laupacis A, Wong C, Churchill D and the Canadian Erythropoietin Study Group. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Controlled Clin. Trials 12, 168S-179S (1991).
  • Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med. Care 30,473–483 (1992).
  • Cagney K, Wu A, Fink N etal. Formal literature review of quality-of-life instruments used in end stage renal disease. Am..j Kidney Dis. 36, 327–336 (2000).
  • ••Excellent review article that summarizesthe HRQOL instruments used in ESRD.
  • Torrance G, Sackett D, Thomas W Utility maximization model for program evaluation: a demonstration application. Hospital Research and Educational Trust, Chicago, IL, USA (1973).
  • •Landmark paper about the TTO technique for measuring preferences.
  • Churchill D, Torrance G, Taylor D eta]. Measurement of quality of life in end stage renal disease: The time-trade-off approach. Clin. Invest. Med. 10, 14–20 (1976).
  • Sesso R, Yoshihiro M. Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial. 7iarisplant. 12, 2111–2116 (1997).
  • Laupacis A, Muirhead N, Keown P, Wong C. A disease specific questionnaire for assessing quality of life in patients on haemodialysis. Nephmn 60, 302–306 (1992).
  • ••Describes the development of the KDQ.
  • Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keane P Disease-specific questionnaire for patients with a renal transplant. Nephron 64, 226–231 (1993).
  • •Describes the development of the KTQ.
  • Hays RD KJ, Mapes DL, Coons SJ, Carter 'NB. Development of the Kidney Disease Quality of Life (KDOOL) Instrument. Quality of Life Res. 3, 329–338 (1994).
  • ••Describes the development of the KDQOL.
  • Carmichael P, Popoolal John I, Stevens P, Carmichael A. Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire. Qual. Life Res. 9, 195–205 (2000).
  • Korevaar J, Merkus M, Jansen M, Dekker F, Boeschoten E, Krediet R, NECOSAD Study Group. Validation of the KDOOL-SF: a dialysis-targeted health measure. Qual. Life Res. 11, 437–447 (2002).
  • Jette AM Davies AR, Cleary PD et al. The Functional Status Questionnaire: reliability and validity when used in primary care. J. Gen. Intern. Med. 1, 143–149 (1986).
  • Sherbourne C. Social functioning: sexual problems measures. In: Measuring Functioning and Will-Being. Stewart AL, Ware JE (Eds), Duke University Press, Durham, NC, USA, 194–204 (1992).
  • Devinsky 0, Vickery B, Cramer J etal. Development of the Quality of Life in Epilepsy (QOLTE) Inventory. 431Iepsia 36, 1989-1104 (1995).
  • Coulter ID, Danielson DC, Hays RD. Measuring chiropractic practitioner satisfaction. Top. ClinChimpract. 3, 65–70 (1996).
  • Hays R. Kidney Disease Quality of Life Short Form (KDQOL-SF). RAND Corp., Santa Monica, CA, USA (1995).
  • Wu A, Fink N, Cagney K etal. Developing a Health-Related Quality-of-Life Measure for End stage Renal Disease: The CHOICE Health Experience Questionnaire. Am. J. Kidney Dis. 37,11-21 (2001).
  • ••Describes the development of the CHEQ.
  • Bass E, Jenckes M, Fink N et at for the CHOICE Study Group. Use of focus groups to identify concerns about dialysis. Med Decis. Making 19,287–295 (1999).
  • Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int. 43\(Suppl. 40), 523—S27 (1993).
  • Kutner N. Assessing end stage renal disease patients' functioning and well being: Measurement approaches and implications for clinical practice. Am..j Kidney Dis. 24, 321–333 (1994).
  • Levinsky N, Mesler D. Measuring, managing and improving the quality of end stage renal disease care. Am. J. 'Wiley Dis. 24,235–246 (1994).
  • Meyer K, Espindle D, DeGiacomo, JM Jenuleson C, Kurtin P, Davies A. Monitoring dialysis patients' health status. Am. J IOdney Dis. 24,267–279 (1994).
  • Kimmel P, Peterson R, Weihs K etal. Behavioral compliance with dialysis prescription in hemodialysis patients. J. Am. Soc. Nephrol 5,1826–1834 (1995).
  • Kimmel P, Weihs K, Peterson R. Survival in hemodialysis patients: The role of depression. Am. J. 'Wiley Dis. jAm. Sc. Nephrol 4,12–27 (1993).
  • Gudex C. Health-related quality of life in end stage renal failure. Qual. Life Res. 4, 359–366 (1995).
  • Rocco M, Gassman J, Wang S, Kaplan R Modification of Diet in Renal Disease Study. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J. ladney Dis. 29(6), 888–896 (1997).
  • Valderrabano E Erythropoietin in chronic renal failure. Kidney Int. 50,1373–1391 (1996).
  • The US Recombinant Human Erythropoietin Predialysis Study Group. Double-blind, placebo-controlled study of the therapeutic use of rHu-EPO for anemia associated with chronic renal failure in predialysis patients. Am. J. Kidney Dis. 18, 50–59 (1991).
  • •Important study describing the effectiveness of erythropoietin in predialysis patients.
  • Revicki D, Brown R, Feeny D etal. Health- related quality of life associated with rHu-EPO therapy for predialysis chronic renal disease patients. Am. J. Kidney Dis. 25, 548–554 (1995).
  • •Important study describing the effectiveness of erythropoietin in predialysis patients.
  • Obrador G, Ruthazer R, Arora P, Kausz A, Pereira B. Prevalence of and factors associated with sub optimal care before initiation of dialysis in the United States. J. Am. Soc. Nephrol 10,1793–1800 (2000).
  • Eknoyan G, Levin N. Clinical Practice Guidelines: Final guidelines summaries from the work groups of the National Kidney Foundation — Dialysis Outcomes Quality Initiative. National Kidney Foundation, New York, NY, USA (1997).
  • Cameron S, Eknoyan G, Danielsen B etal. Target Guideline 5: Target haemoglobin concentration for the treatment of anaemia of chronic renal failure. Nephml Dial 72ansplant. 14 (Suppl.), 511—S13 (1999).
  • Shidler N, Peterson R, Kimmel P Quality of life and psychosocial relationships in patients with chronic renal insufficiency. Am. J IOdney Dis. 32,557–566 (1998).
  • Harris LE, Luft FC, Rudy DVV, Tierney 'NM. Clinical correlates of functional status in patients with chronic renal insufficiency. Am. J IOdney Dis. 21(2), 161–166 (1993).
  • Moreno F, Lopez Gomez J, Sanz G, Jofre R, Valderrabano E The Spanish Co-operative Renal Patients Quality of Life Study Group: quality of life in dialysis patients. Nephrol Dial 72ansplant. 11 (Suppl. 2), S125—S129 (1996).
  • Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Appolone G, for the DIA-QOL. Health-related quality of life in dialysis patients: a report from an Italian study using the SF-36 Health Survey. Nephml. Dial 72ansplant. 14,1503-1510 (1999).
  • Simmons R, Abress L. Quality of life issues for end stage renal disease patients. Am. J. ladney Dis. 15,201–208 (1990).
  • Bakewell A, Higgins R, Me E. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int. 61,239–248 (2002).
  • Kutner N, Devins G. A comparison of the quality of life reported by elderly whites and elderly blacks and dialysis. Geriatr. Nephrol Urol 8,77–83 (1998).
  • Welch J, Austin J. Quality of life in black hemodialysis patients. Adv Ron. Replace Thor. 6,351–357 (1999).
  • Beck A, Ward C, Mendelson M etal. An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561–571 (1961).
  • Bech P Rating scales for affective disorders: their validity and consistency. Acta Ptychiatr Land. 64\(Suppl. 395), 1–101 (1981) .
  • DeOreo P Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization and dialysis-attendance compliance. Am. J. ladney Dis. 30,204–212 (1997).
  • Evans R, Manninen D, Garrison L eta]. The quality of life of patients with end stage renal disease. N Engl. J. Med. 312, 553–559 (1985).
  • •One of the first studies to measure the HRQOL in patients with ESRD.
  • Ware J, Snow K, Kosinski M, Gandek B. SF- 36 Health Survey' Manual and interpretation guide. The Health Institute, New England Medical Center, MA, USA (1993) .
  • Nerenz D, Repasky D, Whitehouse F, Kahkomen D. Ongoing assessment of health status in patients with diabetes mellitus. Med. Care 30, M5112–124 (1992).
  • Shekelle P, Hays R, Kallich J. Quality of life of Veterans with COPD/Asthma: Project Memorandum, RAND Corp., Santa Monica, CA, USA (1994).
  • Simmons R, Anderson C, Abress L. Quality of life and rehabilitation differences among four end stage renal disease therapy groups. Scand. I Um]. Nephrol 24\(Suppl. 131), S7—S22 (1990).
  • Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Lit. 50,235–242 (1996).
  • Hilbrands L, Hoitsma A, Koene R. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 59,1263–1270 (1995).
  • Merkus MP, Jager KS, Dekker FW et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am. J. ladney Dis. 29, 584–592 (1997).
  • Mittal S, Ahem L, Flaster E, Mittal V, Maesaka J, Fishbane S. Self-assessed quality of life in peritoneal dialysis patients. Am J. Nephrol 21,215–220 (2001).
  • Korevaar J, Jansen M, Merkus M et al, for the NECOSAD Study Group. Quality of life in predialysis end stage renal disease patients at the initiation of dialysis therapy. Peritoneal Dialysis Int. 20, 69–75 (2000).
  • Korevaar J, Maartin A, Jansen M eta]., for the NECOSAD Study Group. Evaluation of DOQI Guidelines: early start of dialysis treatment is not associated with better health-related quality of life. Am. J. Kidney Dir. 29, 108–115 (2002).
  • Hamilton G, Locking-Cusolito H. The relationship between dialysis adequacy and quality of life: a report of a pilot study. CAIVNT (8–3), 25–29 (1998).
  • Rebollo P Ortega F, Baltar J eta]. Health- related quality of life (HRQ0L) in end stage renal disease (ESRD) in patients over 65 years. Geriatric Nqgliml Umi 8, 85–94 (1998).
  • Lamping D, Constantinovici N, Roderick P eta]. Clinical outcomes, quality of life and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet356, 1543–1550 (2000).
  • Royse D, Toler J. Dialysis patients and patterns of symptom report on the symptom checklist 90R. Psycho]. Rep. 62, 827–831 (1988).
  • Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, VVare JE Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J. Am. Soc. Nephrol 7(5), 763–773 (1996).
  • Kaplan R, Mehta R. Outcome measurement in kidney disease. Blood Puril 12, 20–29 (1994).

Website

  • US Renal Data System. Annual Data Report: Atlas of End stage Renal Disease in the United States. Chapter 1: Incidence and Prevalence. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA (2002). www.usrds.org/atlas.htm Accessed October 1, 2002.
  • ••Comprehensive document, published annually, by the US Renal Data System.
  • The Problem of Kidney and Urologic Disease. National Kidney Foundation. www.kidney.org/general/news/ problem_disease.cfm Accessed November 20, 2002.
  • •Provides quick facts about kidney disease, from the US National Kidney Foundation.
  • National Kidney Foundation Kidney Dialysis Outcomes Quality Initiative Guidelines. Part 4. Definition and classification of stages of chronic kidney disease. www.kidney.org/professionals/ doqi/kdoqi/p4_class_gl .htm Accessed October 15, 2002.
  • ••Important reference document.
  • US Renal Data System. Annual Data Report: Atlas of End stage Renal Disease in the United States. Chapter 12: Economic Costs of ESRD. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, USA (2002). www.usrds.org/atlas.htm Accessed October 1,2002. Comprehensive document, published annually, by the US Renal Data System.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.